Stay updated on Moderna Press Releases
Sign up to get notified when there's something new on the Moderna Press Releases page.

Latest updates to the Moderna Press Releases page
- ChecktodayChange DetectedThe news list now features Moderna’s recognition as a top employer and an upcoming presentation of Phase 3 trial results at ESMO 2026. Earlier releases about an influenza vaccine approval and an Ebola vaccine trial initiation no longer appear.SummaryDifference5%

- Check7 days agoChange DetectedModerna’s press release listing now includes an October 13, 2026 announcement that it will report third-quarter 2026 financial results on November 6, replacing the July 31 announcement about second-quarter results. The displayed stock quote and trading volume also changed.SummaryDifference1%

- Check14 days agoChange DetectedModerna’s NASD stock quote changed from $190.01 with 10.29M volume to $225.00 with 28.95M volume.SummaryDifference0.4%

- Check21 days agoChange DetectedThe latest press release announces a new Chief Operating Officer role tied to Moderna’s expansion into oncology, replacing an older Phase 1 cancer-therapy trial announcement in the displayed list. The accompanying stock quote and trading volume also changed.SummaryDifference1%

- Check28 days agoChange DetectedA new stock price and trading volume are added, and a new press release headline about ESMO 2026 is posted for September 21, 2026. The deletions remove older stock figures and a prior quarterly results post, updating the page's investor news timeline.SummaryDifference1%

- Check35 days agoChange DetectedThe header stock quote and trading volume updated from $143.97 / 15.41M to $154.04 / 20.24M, reflecting the latest market data displayed on the page.SummaryDifference0.4%

Stay in the know with updates to Moderna Press Releases
Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.